Cargando…
ACT-3 Reactor-based boron neutron capture therapy with add-on bevacizumab for recurrent malignant glioma: The final report
Background: Re-irradiation had a higher rate of radiation injury because recurrent MG had already irradiated in the first-line treatment. Recently, combination therapy of re-irradiation and bevacizumab showed a lower incidence of radiation injury than re-irradiation alone. Boron neutron capture ther...
Autores principales: | Furuse, Motomasa, Kawabata, Shinji, Wanibuchi, Masahiko, Shiba, Hiroyuki, Takeuchi, Koji, Kondo, Natsuko, Tanaka, Hiroki, Sakurai, Yoshinori, Suzuki, Minoru, Ono, Koji, Miyatake, Shin-Ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8664641/ http://dx.doi.org/10.1093/noajnl/vdab159.034 |
Ejemplares similares
-
Reactor-based boron neutron capture therapy for 44 cases of recurrent and refractory high-grade meningiomas with long-term follow-up
por: Takai, Satoshi, et al.
Publicado: (2021) -
Boron Neutron Capture Therapy Combined with Early Successive Bevacizumab Treatments for Recurrent Malignant Gliomas – A Pilot Study
por: SHIBA, Hiroyuki, et al.
Publicado: (2018) -
ACT-02 BORON NEUTRONS CAPTURE THERAPY FOR RECURRENT HIGH-GRADE MENINGIOMAS, FROM REACTOR TO ACCELERATOR
por: Miyatake, Shin-Ichi, et al.
Publicado: (2019) -
RT-06 PLANNING OF BORON NEUTRON CAPTURE THERAPY (BNCT) USING POSITRON EMISSION TOMOGRAPHY (PET)
por: Kawabata, Shinji, et al.
Publicado: (2019) -
Boron neutron capture therapy with bevacizumab may prolong the survival of recurrent malignant glioma patients: four cases
por: Miyatake, Shin-Ichi, et al.
Publicado: (2014)